Search research articles
Contact Us
Filters
Showing results (181-190 of 212) with videos related to
Page
of 22
Sort By:
CJC Open
|
December 23, 2022
Design and Rationale of Routine <b>U</b>ltrasou<b>N</b>d Gu<b>I</b>dance for <b>V</b>ascular Acc<b>E</b>ss fo<b>R</b> Cardiac Procedure<b>s</b>: <b>A</b> Randomized Tria<b>L</b> (UNIVERSAL)
Sulaiman Alrashidi, Marc-André d'Entremont, Omar Alansari, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
August 22, 2018
Clinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency department
Peter A Kavsak, Johannes T Neumann, Louise Cullen, et al.
The Canadian Journal of Cardiology
|
February 25, 2018
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy
Shamir R Mehta, Kevin R Bainey, Warren J Cantor, et al.
Journal of the American College of Cardiology
|
November 30, 2019
Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial
David A Wood, John A Cairns, Jia Wang, et al.
The American Journal of Cardiology
|
October 8, 2023
Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial
Usman Baber, Alessandro Spirito, Samantha Sartori, et al.
JAMA Cardiology
|
September 18, 2022
Routine Ultrasonography Guidance for Femoral Vascular Access for Cardiac Procedures: The UNIVERSAL Randomized Clinical Trial
Sanjit S Jolly, Sulaiman AlRashidi, Marc-André d'Entremont, et al.
American Heart Journal
|
March 8, 2024
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial
Mitchell Krucoff, Alessandro Spirito, Usman Baber, et al.
Lancet (London, England)
|
September 7, 2010
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
Shamir R Mehta, Jean-Francois Tanguay, John W Eikelboom, et al.
European Heart Journal. Digital Health
|
March 20, 2025
Artificial intelligence for the analysis of intracoronary optical coherence tomography images: a systematic review
Ruben G A van der Waerden, Rick H J A Volleberg, Thijs J Luttikholt, et al.
The Canadian Journal of Cardiology
|
April 18, 2020
Precautions and Procedures for Coronary and Structural Cardiac Interventions During the COVID-19 Pandemic: Guidance from Canadian Association of Interventional Cardiology
David A Wood, Janarthanan Sathananthan, Ken Gin, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 212) with videos related to
Sort By:
Page
of 22
CJC Open
|
December 23, 2022
Design and Rationale of Routine <b>U</b>ltrasou<b>N</b>d Gu<b>I</b>dance for <b>V</b>ascular Acc<b>E</b>ss fo<b>R</b> Cardiac Procedure<b>s</b>: <b>A</b> Randomized Tria<b>L</b> (UNIVERSAL)
Sulaiman Alrashidi, Marc-André d'Entremont, Omar Alansari, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
August 22, 2018
Clinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency department
Peter A Kavsak, Johannes T Neumann, Louise Cullen, et al.
The Canadian Journal of Cardiology
|
February 25, 2018
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy
Shamir R Mehta, Kevin R Bainey, Warren J Cantor, et al.
Journal of the American College of Cardiology
|
November 30, 2019
Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial
David A Wood, John A Cairns, Jia Wang, et al.
The American Journal of Cardiology
|
October 8, 2023
Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial
Usman Baber, Alessandro Spirito, Samantha Sartori, et al.
JAMA Cardiology
|
September 18, 2022
Routine Ultrasonography Guidance for Femoral Vascular Access for Cardiac Procedures: The UNIVERSAL Randomized Clinical Trial
Sanjit S Jolly, Sulaiman AlRashidi, Marc-André d'Entremont, et al.
American Heart Journal
|
March 8, 2024
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial
Mitchell Krucoff, Alessandro Spirito, Usman Baber, et al.
Lancet (London, England)
|
September 7, 2010
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
Shamir R Mehta, Jean-Francois Tanguay, John W Eikelboom, et al.
European Heart Journal. Digital Health
|
March 20, 2025
Artificial intelligence for the analysis of intracoronary optical coherence tomography images: a systematic review
Ruben G A van der Waerden, Rick H J A Volleberg, Thijs J Luttikholt, et al.
The Canadian Journal of Cardiology
|
April 18, 2020
Precautions and Procedures for Coronary and Structural Cardiac Interventions During the COVID-19 Pandemic: Guidance from Canadian Association of Interventional Cardiology
David A Wood, Janarthanan Sathananthan, Ken Gin, et al.
Page
of 22